170 related articles for article (PubMed ID: 35566215)
1. New Derivatives of 5-Substituted Uracils: Potential Agents with a Wide Spectrum of Biological Activity.
Kezin VA; Matyugina ES; Novikov MS; Chizhov AO; Snoeck R; Andrei G; Kochetkov SN; Khandazhinskaya AL
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566215
[TBL] [Abstract][Full Text] [Related]
2. 5-(1-Substituted) alkyl pyrimidine nucleosides as antiviral (herpes) agents.
Kumar R
Curr Med Chem; 2004 Oct; 11(20):2749-66. PubMed ID: 15544474
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of (E)-5-(2-bromovinyl)uracil and related pyrimidine nucleosides as antiviral agents for herpes viruses.
Choi Y; Li L; Grill S; Gullen E; Lee CS; Gumina G; Tsujii E; Cheng YC; Chu CK
J Med Chem; 2000 Jun; 43(13):2538-46. PubMed ID: 10891113
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
[TBL] [Abstract][Full Text] [Related]
5. 3'-Spiro nucleosides, a new class of specific human immunodeficiency virus type 1 inhibitors: synthesis and antiviral activity of [2'-5'-bis-O-(tert-butyldimethylsilyl)-beta-D-xylo- and -ribofuranose]-3'-spiro-5"-[4"-amino-1",2"-oxathiole 2",2"-dioxide] (TSAO) pyrimidine nucleosides.
Camarasa MJ; Pérez-Pérez MJ; San-Félix A; Balzarini J; De Clercq E
J Med Chem; 1992 Jul; 35(15):2721-7. PubMed ID: 1495006
[TBL] [Abstract][Full Text] [Related]
6. Antiviral and Cytostatic Evaluation of 5-(1-Halo-2-sulfonylvinyl)- and 5-(2-Furyl)uracil Nucleosides.
Wen Z; Suzol SH; Peng J; Liang Y; Snoeck R; Andrei G; Liekens S; Wnuk SF
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28304114
[TBL] [Abstract][Full Text] [Related]
7. 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase.
Balzarini J; Pérez-Pérez MJ; San-Félix A; Schols D; Perno CF; Vandamme AM; Camarasa MJ; De Clercq E
Proc Natl Acad Sci U S A; 1992 May; 89(10):4392-6. PubMed ID: 1374900
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiviral activity of novel acyclic nucleoside analogues of 5-(1-azido-2-haloethyl)uracils.
Kumar R; Sharma N; Nath M; Saffran HA; Tyrrell DL
J Med Chem; 2001 Nov; 44(24):4225-9. PubMed ID: 11708924
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiherpesvirus activities of 5-alkyl-2-thiopyrimidine nucleoside analogues.
Shigeta S; Mori S; Watanabe F; Takahashi K; Nagata T; Koike N; Wakayama T; Saneyoshi M
Antivir Chem Chemother; 2002 Mar; 13(2):67-82. PubMed ID: 12238531
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric synthesis and biological evaluation of beta-L-(2R,5S)- and alpha-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents.
Jeong LS; Schinazi RF; Beach JW; Kim HO; Nampalli S; Shanmuganathan K; Alves AJ; McMillan A; Chu CK; Mathis R
J Med Chem; 1993 Jan; 36(2):181-95. PubMed ID: 8423591
[TBL] [Abstract][Full Text] [Related]
11. Nucleoside analogues exerting antiviral activity through a non-nucleoside mechanism.
De Clercq E
Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):457-70. PubMed ID: 15043166
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the antiprotozoan properties of 5'-norcarbocyclic pyrimidine nucleosides.
Alzahrani KJ; Matyugina ES; Khandazhinskaya AL; Kochetkov SN; Seley-Radtke KL; Koning HP
Bioorg Med Chem Lett; 2017 Jul; 27(14):3081-3086. PubMed ID: 28571825
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of pyrimidine nucleosides as antiviral agents for human immunodeficiency virus type 1 in peripheral blood mononuclear cells.
Chu CK; Schinazi RF; Ahn MK; Ullas GV; Gu ZP
J Med Chem; 1989 Mar; 32(3):612-7. PubMed ID: 2918508
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiviral activity of 3'-deoxy-3'-C-hydroxymethyl nucleosides.
Bamford MJ; Coe PL; Walker RT
J Med Chem; 1990 Sep; 33(9):2494-501. PubMed ID: 2167981
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of beta-D-(2S,5R)- and alpha-D-(2S,5S)-1,3-oxathiolanyl nucleosides as potential anti-HIV agents.
Jeong LS; Schinazi RF; Beach JW; Kim HO; Shanmuganathan K; Nampalli S; Chun MW; Chung WK; Choi BG; Chu CK
J Med Chem; 1993 Sep; 36(18):2627-38. PubMed ID: 8410975
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMV.
Maruyama T; Kozai S; Yamasaki T; Witvrouw M; Pannecouque C; Balzarini J; Snoeck R; Andrei G; De Clercq E
Antivir Chem Chemother; 2003 Sep; 14(5):271-9. PubMed ID: 14694990
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activities of pyrimidine nucleoside analogues: some structure--activity relationships.
Dragún M; Rada B; Novotný L; Beránek J
Acta Virol; 1990 Aug; 34(4):321-9. PubMed ID: 1981442
[TBL] [Abstract][Full Text] [Related]
18. Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication.
Balzarini J; McGuigan C
J Antimicrob Chemother; 2002 Jul; 50(1):5-9. PubMed ID: 12096000
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel 5-substituted acyclic pyrimidine nucleosides as potent and selective inhibitors of hepatitis B virus.
Kumar R; Nath M; Tyrrell DL
J Med Chem; 2002 May; 45(10):2032-40. PubMed ID: 11985471
[TBL] [Abstract][Full Text] [Related]
20. Activity of acyclic 6-(phenylselenenyl)pyrimidine nucleosides against human immunodeficiency viruses in primary lymphocytes.
Goudgaon NM; Schinazi RF
J Med Chem; 1991 Nov; 34(11):3305-9. PubMed ID: 1720175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
